Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

ADVANCES IN THE CELL-BASED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY.

Pabon MM, Borlongan CV.

Future Neurol. 2013 Mar 1;8(2):193-203.

2.

Stem cell therapy for neonatal hypoxic-ischemic encephalopathy.

Gonzales-Portillo GS, Reyes S, Aguirre D, Pabon MM, Borlongan CV.

Front Neurol. 2014 Aug 12;5:147. doi: 10.3389/fneur.2014.00147. eCollection 2014. Review.

3.

Advancing critical care medicine with stem cell therapy and hypothermia for cerebral palsy.

Dailey T, Mosley Y, Pabon M, Acosta S, Tajiri N, van Loveren H, Kaneko Y, Borlongan CV.

Neuroreport. 2013 Dec 18;24(18):1067-71. doi: 10.1097/WNR.0000000000000062. Review.

4.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

5.

Baby STEPS: a giant leap for cell therapy in neonatal brain injury.

Borlongan CV, Weiss MD.

Pediatr Res. 2011 Jul;70(1):3-9. doi: 10.1203/PDR.0b013e31821d0d00. Review.

6.

Cell therapy for neonatal hypoxia-ischemia and cerebral palsy.

Bennet L, Tan S, Van den Heuij L, Derrick M, Groenendaal F, van Bel F, Juul S, Back SA, Northington F, Robertson NJ, Mallard C, Gunn AJ.

Ann Neurol. 2012 May;71(5):589-600. doi: 10.1002/ana.22670. Review.

PMID:
22522476
7.

Neural stem cell therapies and hypoxic-ischemic brain injury.

Huang L, Zhang L.

Prog Neurobiol. 2018 May 11. pii: S0301-0082(17)30113-2. doi: 10.1016/j.pneurobio.2018.05.004. [Epub ahead of print] Review.

PMID:
29758244
8.

Adult stem cell therapy for acute brain injury in children.

Carroll JE, Borlongan CV.

CNS Neurol Disord Drug Targets. 2008 Oct;7(4):361-9. Review.

PMID:
18991664
9.

Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II.

Savitz SI, Chopp M, Deans R, Carmichael T, Phinney D, Wechsler L; STEPS Participants.

Stroke. 2011 Mar;42(3):825-9. doi: 10.1161/STROKEAHA.110.601914. Epub 2011 Jan 27.

10.

Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke.

van Velthoven CT, Sheldon RA, Kavelaars A, Derugin N, Vexler ZS, Willemen HL, Maas M, Heijnen CJ, Ferriero DM.

Stroke. 2013 May;44(5):1426-32. doi: 10.1161/STROKEAHA.111.000326. Epub 2013 Mar 28.

11.

Neonatal brain injury as a consequence of insufficient cerebral oxygenation.

Placha K, Luptakova D, Baciak L, Ujhazy E, Juranek I.

Neuro Endocrinol Lett. 2016;37(2):79-96.

PMID:
27179569
12.

A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells.

Glover LE, Tajiri N, Weinbren NL, Ishikawa H, Shinozuka K, Kaneko Y, Watterson DM, Borlongan CV.

Transl Stroke Res. 2012 Mar;3(1):90-8. doi: 10.1007/s12975-011-0127-8. Epub 2011 Nov 18.

13.

Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury.

Yasuhara T, Matsukawa N, Yu G, Xu L, Mays RW, Kovach J, Deans RJ, Hess DC, Carroll JE, Borlongan CV.

Cell Transplant. 2006;15(3):231-8.

PMID:
16719058
14.
15.

Hypothermia for hypoxic-ischemic encephalopathy.

Cotten CM, Shankaran S.

Expert Rev Obstet Gynecol. 2010 Mar 1;5(2):227-239.

16.

A novel reproducible model of neonatal stroke in mice: comparison with a hypoxia-ischemia model.

Tsuji M, Ohshima M, Taguchi A, Kasahara Y, Ikeda T, Matsuyama T.

Exp Neurol. 2013 Sep;247:218-25. doi: 10.1016/j.expneurol.2013.04.015. Epub 2013 May 4.

PMID:
23651512
17.

Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.

Rogers EE, Bonifacio SL, Glass HC, Juul SE, Chang T, Mayock DE, Durand DJ, Song D, Barkovich AJ, Ballard RA, Wu YW.

Pediatr Neurol. 2014 Nov;51(5):657-62. doi: 10.1016/j.pediatrneurol.2014.08.010. Epub 2014 Aug 27.

18.

[Changes of neural stem cells in neonatal rat model of hypoxic-ischemic encephalopathy].

Yin XJ, Ju R, Feng ZC.

Zhonghua Er Ke Za Zhi. 2005 Aug;43(8):572-5. Chinese.

PMID:
16191263
19.

Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.

Wei N, Yu SP, Gu X, Taylor TM, Song D, Liu XF, Wei L.

Cell Transplant. 2013;22(6):977-91. doi: 10.3727/096368912X657251. Epub 2012 Oct 2.

PMID:
23031629
20.

Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.

Kumral A, Yesilirmak DC, Sonmez U, Baskin H, Tugyan K, Yilmaz O, Genc S, Gokmen N, Genc K, Duman N, Ozkan H.

Brain Res. 2006 Oct 18;1115(1):169-78. Epub 2006 Aug 30.

PMID:
16938277

Supplemental Content

Support Center